circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis

Antoni, 2017, Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends, Eur. Urol., 71, 96, 10.1016/j.eururo.2016.06.010 Cowan, 2004, Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 59, 197, 10.1016/j.ijrobp.2003.10.018 Abufaraj, 2018, The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review, Eur. Urol., 73, 543, 10.1016/j.eururo.2017.09.030 Memczak, 2013, Circular RNAs are a large class of animal RNAs with regulatory potency, Nature, 495, 333, 10.1038/nature11928 Ju, 2019, A circRNA signature predicts postoperative recurrence in stage II/III colon cancer, EMBO Mol. Med., 11, e10168, 10.15252/emmm.201810168 Ng, 2018, Functional role of circular RNAs in cancer development and progression, RNA Biol., 15, 995 Li, 2019, Circular RNAs as promising biomarkers in cancer: detection, function, and beyond, Genome Med., 11, 15, 10.1186/s13073-019-0629-7 Wang, 2020, CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway, J. Exp. Clin. Cancer Res., 39, 169, 10.1186/s13046-020-01679-8 Xia, 2020, Circular RNA circTNPO3 Regulates Paclitaxel Resistance of Ovarian Cancer Cells by miR-1299/NEK2 Signaling Pathway, Mol. Ther. Nucleic Acids, 21, 780, 10.1016/j.omtn.2020.06.002 Li, 2020, Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab, Mol. Cancer, 19, 142, 10.1186/s12943-020-01259-6 Zhang, 2015, PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma, Cancer Lett., 367, 49, 10.1016/j.canlet.2015.07.010 Xiong, 2019, NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation, Theranostics, 9, 7156, 10.7150/thno.36030 Schmitz-Dräger, 1997, p53 and MDM2 in the development and progression of bladder cancer, Eur. Urol., 32, 487, 10.1159/000480813 Hosono, 2017, Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA, Cell, 171, 1559, 10.1016/j.cell.2017.11.040 Spizzo, 2012, Long non-coding RNAs and cancer: a new frontier of translational research?, Oncogene, 31, 4577, 10.1038/onc.2011.621 Jin, 2020, Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548, J. Exp. Clin. Cancer Res., 39, 186, 10.1186/s13046-020-01697-6 Su, 2020, circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway, Mol. Cancer, 19, 23, 10.1186/s12943-019-1129-5 Feng, 2018, miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC, Bratisl. Lek Listy, 119, 60 Wang, 2017, miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis, Int. J. Biol. Sci., 13, 122, 10.7150/ijbs.14770 Ye, 2020, MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect, Front. Cell Dev. Biol., 8, 615154, 10.3389/fcell.2020.615154 Guarnerio, 2019, Intragenic antagonistic roles of protein and circRNA in tumorigenesis, Cell Res., 29, 628, 10.1038/s41422-019-0192-1 Liang, 2017, The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting, Mol. Cell, 68, 940, 10.1016/j.molcel.2017.10.034 Konopleva, 2020, MDM2 inhibition: an important step forward in cancer therapy, Leukemia, 34, 2858, 10.1038/s41375-020-0949-z Wu, 2017, MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2, Oncol. Rep., 37, 3502, 10.3892/or.2017.5607 Oliner, 2016, The Role of MDM2 Amplification and Overexpression in Tumorigenesis, Cold Spring Harb. Perspect. Med., 6, a026336, 10.1101/cshperspect.a026336 Finlay, 1993, The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth, Mol. Cell. Biol., 13, 301 Jones, 1998, Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis, Proc. Natl. Acad. Sci. USA, 95, 15608, 10.1073/pnas.95.26.15608 Ciccarese, 2017, Tp53 and its potential therapeutic role as a target in bladder cancer, Expert Opin. Ther. Targets, 21, 401, 10.1080/14728222.2017.1297798 Garczyk, 2020, Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder, Am. J. Pathol., 190, 323, 10.1016/j.ajpath.2019.10.004 Kim, 2020, MDM2-C Functions as an E3 Ubiquitin Ligase, Cancer Manag. Res., 12, 7715, 10.2147/CMAR.S260943 Chen, 2020, Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis, J. Exp. Clin. Cancer Res., 39, 94, 10.1186/s13046-020-01592-0